Metastatic Nasopharyngeal Carcinoma Outcomes in Patients on Cisplatin with Nolatrexed or 5-Fluorouracil

Publisher： Karger

E-ISSN： 2296-5262|37|10|540-544

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.37, Iss.10, 2014-09, pp. : 540-544

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Locoregionally Advanced Nasopharyngeal Carcinoma: Induction Chemotherapy with Cisplatin and 5-Fluorouracil Followed by Radiotherapy and Concurrent Cisplatin

By  

Oncology, Vol. 74, Iss. 3-4, 2008-08 ,pp. : 158-166

Karger

Access to resources Recommend Favorite

Phase II Study of Cisplatin and Dacarbazine for Metastatic Colorectal Carcinoma Resistant to 5-Fluorouracil

By  

Oncology, Vol. 56, Iss. 4, 1999-05 ,pp. : 297-300

Karger

Access to resources Recommend Favorite

Phase II Study of Cisplatin and 5-Fluorouracil (PF) and Mitomycin C, Vincristine, Cisplatin and 5-Fluorouracil (MVPF) in Patients with Metastatic Large Bowel Cancer: An Eastern Cooperative Oncology Group Study (EST 1285)

By  

Oncology, Vol. 66, Iss. 2, 2004-05 ,pp. : 118-125

Karger

Access to resources Recommend Favorite

Phase 1 study of cetuximab in combination with 5‐fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma

By  

CANCER, Vol. 119, Iss. 16, 2013-08 ,pp. : 2973-2980

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cisplatin, Raltitrexed, Levofolinic Acid and 5-Fluorouracil in Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Phase II Randomized Study

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 232-238

Karger

Access to resources Recommend Favorite